McNeil Expands Tylenol Recall As FDA Criticizes Firm's Response To AERs
This article was originally published in The Tan Sheet
McNeil Consumer Healthcare's reaction to signs of potentially contaminated packaging for OTC products including Tylenol raised FDA's ire and is now costing the firm an extensive product recall
You may also be interested in...
J&J Woes, Pharma Switch Outlook Lead "The Tan Sheet" 2010 Topics
Quality control problems for Johnson & Johnson's McNeil Consumer Healthcare business and the regulatory and congressional scrutiny that followed dominated the attention of drug and dietary supplement industry stakeholders in 2010.
St. Joseph Aspirin Is First J&J/McNeil Divestiture From 2010 OTC Recalls
Johnson & Johnson unloads St. Joseph Aspirin, an OTC brand that suffered a significant dip in sales following a 2010 recall due to contaminated packaging.
Prestige Brands buys Dramamine